Position in AZN
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$166,591,930
New position
Shares Held
844,701
first reported quarter
Ownership
0.054%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Derivatives in AZN
reported options exposure · as of Mar 31, 2026CallValue
$65,881,341
CallShares
334,050
PutValue
$26,575,395
PutShares
134,750
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026JANE STREET GROUP, LLC holds $859,838,957 across 13 Drug Manufacturers - General names. AZN ranks #1 (19.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
This page
|
844,701 | $166,591,930 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
2,265,508 | $137,403,059 | |
| 3 | LLY |
ELI LILLY & Co
|
115,863 | $106,567,309 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
666,637 | $92,909,198 | |
| 5 | NVO |
Novo Nordisk A S
|
2,024,007 | $74,382,257 | |
| 6 | NVS |
Novartis AG
|
366,467 | $55,977,834 | |
| 7 | PFE |
Pfizer Inc
|
1,883,213 | $52,880,620 | |
| 8 | MRK |
Merck & Co., Inc.
|
351,131 | $42,237,546 |
All Filings in AZN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $65,881,341 | 334,050 | Call | Defined | 2026-05-12 | |
| 2026-03-31 | $26,575,395 | 134,750 | Put | Defined | 2026-05-12 | |
| 2026-03-31 | $166,591,930 | 844,701 | Shares | Defined | 2026-05-12 | |
| No filing history on record for this holder in this stock. | ||||||